174 related articles for article (PubMed ID: 30411520)
1. Association between chest computed tomography findings and respiratory adverse events in rheumatoid arthritis patients undergoing long-term biological therapy.
Matsumoto T; Iwano S; Takahashi N; Asai S; Watanabe T; Asai N; Sobue Y; Ito S; Ishiguro N; Kojima T
Int J Rheum Dis; 2019 Apr; 22(4):626-635. PubMed ID: 30411520
[TBL] [Abstract][Full Text] [Related]
2. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
[TBL] [Abstract][Full Text] [Related]
3. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
[TBL] [Abstract][Full Text] [Related]
4. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
[TBL] [Abstract][Full Text] [Related]
5. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Koo BS; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Korean J Intern Med; 2015 Jan; 30(1):104-9. PubMed ID: 25589842
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
Ota M; Iwasaki Y; Harada H; Sasaki O; Nagafuchi Y; Nakachi S; Sumitomo S; Shoda H; Tohma S; Fujio K; Yamamoto K
Mod Rheumatol; 2017 Jan; 27(1):22-28. PubMed ID: 27142966
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
8. Visual Assessment of Chest Computed Tomography Findings in Anti-cyclic Citrullinated Peptide Antibody Positive Rheumatoid Arthritis: Is it Associated with Airway Abnormalities?
Park WH; Kim SS; Shim SC; Song ST; Jung SS; Kim JH; Kim N; Seo JB
Lung; 2016 Feb; 194(1):97-105. PubMed ID: 26608346
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
Zhang Y; Li H; Wu N; Dong X; Zheng Y
Clin Rheumatol; 2017 Apr; 36(4):817-823. PubMed ID: 28191607
[TBL] [Abstract][Full Text] [Related]
10. Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials.
Citera G; Mysler E; Madariaga H; Cardiel MH; Castañeda O; Fischer A; Richette P; Chartrand S; Park JK; Strengholt S; Rivas JL; Thorat AV; Girard T; Kwok K; Wang L; Ponce de Leon D
J Clin Rheumatol; 2021 Dec; 27(8):e482-e490. PubMed ID: 32826657
[TBL] [Abstract][Full Text] [Related]
11. Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
Honne K; Bando M; Mieno MN; Iwamoto M; Minota S
Rheumatol Int; 2022 Aug; 42(8):1341-1346. PubMed ID: 34251498
[TBL] [Abstract][Full Text] [Related]
12. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry.
Narongroeknawin P; Chevaisrakul P; Kasitanon N; Kitumnuaypong T; Mahakkanukrauh A; Siripaitoon B; Katchamart W;
Int J Rheum Dis; 2018 Jan; 21(1):170-178. PubMed ID: 28737837
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis-related lung diseases: CT findings.
Tanaka N; Kim JS; Newell JD; Brown KK; Cool CD; Meehan R; Emoto T; Matsumoto T; Lynch DA
Radiology; 2004 Jul; 232(1):81-91. PubMed ID: 15166329
[TBL] [Abstract][Full Text] [Related]
14. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
15. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
[TBL] [Abstract][Full Text] [Related]
16. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
17. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Clin Rheumatol; 2016 Oct; 35(10):2585-9. PubMed ID: 27448151
[TBL] [Abstract][Full Text] [Related]
19. Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study.
Lampropoulos CE; Orfanos P; Bournia VK; Karatsourakis T; Mavragani C; Pikazis D; Manoussakis MN; Tzioufas AG; Moutsopoulos HM; Vlachoyiannopoulos PG
Clin Exp Rheumatol; 2015; 33(2):216-24. PubMed ID: 25664400
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
